Drosophila as an In Vivo Model for Human Neurodegenerative Disease

L McGurk, A Berson, NM Bonini - Genetics, 2015 - academic.oup.com
With the increase in the ageing population, neurodegenerative disease is devastating to
families and poses a huge burden on society. The brain and spinal cord are extraordinarily …

What genetics tells us about the causes and mechanisms of Parkinson's disease

O Corti, S Lesage, A Brice - Physiological reviews, 2011 - journals.physiology.org
Parkinson's disease (PD) is a common motor disorder of mysterious etiology. It is due to the
progressive degeneration of the dopaminergic neurons of the substantia nigra and is …

[HTML][HTML] PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility

X Wang, D Winter, G Ashrafi, J Schlehe, YL Wong… - Cell, 2011 - cell.com
Cells keep their energy balance and avoid oxidative stress by regulating mitochondrial
movement, distribution, and clearance. We report here that two Parkinson's disease …

Genetic animal models of Parkinson's disease

TM Dawson, HS Ko, VL Dawson - Neuron, 2010 - cell.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized
by the degeneration of dopamine (DA) and non-DA neurons, the almost uniform presence of …

An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene–environment interactions

ME Johnson, L Bobrovskaya - Neurotoxicology, 2015 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder that is
characterized by two major neuropathological hallmarks: the degeneration of dopaminergic …

Emerging roles of Wnts in the adult nervous system

NC Inestrosa, E Arenas - Nature Reviews Neuroscience, 2010 - nature.com
The roles of the Wnt signalling pathway in several developmental processes, including
synaptic differentiation, are well characterized. The expression of Wnt ligands and Wnt …

The role of the LRRK2 gene in Parkinsonism

JQ Li, L Tan, JT Yu - Molecular neurodegeneration, 2014 - Springer
Abstract Parkinson's disease (PD), like many common age-related conditions, has been
recognized to have a substantial genetic component. Multiple lines of evidence suggest that …

Advancement in the modelling and therapeutics of Parkinson's disease

SN Rai, P Singh - Journal of chemical neuroanatomy, 2020 - Elsevier
Since the discovery of L-dopa in the middle of the 20th century (1960s), there is not any
neuroprotective therapy available although significant development has been made in the …

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

X Wang, MH Yan, H Fujioka, J Liu… - Human molecular …, 2012 - academic.oup.com
The leucine-rich repeat kinase 2 (LRRK2) mutations are the most common cause of
autosomal-dominant Parkinson disease (PD). Mitochondrial dysfunction represents a critical …

Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease

JM Taylor, BS Main, PJ Crack - Neurochemistry international, 2013 - Elsevier
Parkinson's disease (PD) is a complex disease, with genetics and environment contributing
to the disease onset. Recent studies of causative PD genes have confirmed the involvement …